Evidence-based colloid use in the critically ill: American Thoracic Society consensus statement

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 11, 2004, Pages 1247-1259

[No Author Info available]

Author keywords

Albumins; Clinical trials; Colloids; Critical care; Dextrans; Gelatin; Hetastarch; Intensive care; International cooperation; Isotonic solutions; Outcome assessment; Plasma substitute

Indexed keywords

ALBUMIN; ANTIINFECTIVE AGENT; ARACHIDONIC ACID; DEXTRAN 40; DEXTRAN 70; DIGOXIN; FUROSEMIDE; GELATIN; HETASTARCH; MIDAZOLAM; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; STARCH; THIOPENTAL; WARFARIN;

ACUTE KIDNEY FAILURE; ANTIINFLAMMATORY ACTIVITY; BACTERIAL PERITONITIS; BLOOD VESSEL PERMEABILITY; BRAIN ISCHEMIA; CARDIOGENIC SHOCK; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COCHRANE LIBRARY; COLLOID; CONSENSUS DEVELOPMENT; CRITICAL ILLNESS; CRYSTALLOID; DRUG BINDING; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE ORGANIZATION; HEMOSTASIS; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; INFORMATION RETRIEVAL; INJURY; INTENSIVE CARE UNIT; INTESTINE ISCHEMIA; LUNG INJURY; MEDLINE; META ANALYSIS; MORTALITY; NEUTROPHIL; NONHUMAN; ONCOTIC PRESSURE; PARACENTESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESUSCITATION; REVIEW; SEPTIC SHOCK; SHOCK; SIDE EFFECT; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE;

COLLOIDS; CRITICAL CARE; CRITICAL ILLNESS; FLUID THERAPY; HUMANS;

EID: 9644279408     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200208-909ST     Document Type: Review

References (237)

1. Virgilio RW, Rice CL, Smith DE, James DR, Zarins CK, Hobelmann CF, Peters RM. Crystalloid vs. colloid resuscitation: is one better? A randomized clinical study. Surgery 1979;85:129-139.
2. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998;316:961-964.
3. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998;317:235-240.
4. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999;27:200-210.
5. Wilkes MM, Navickis RJ. Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med 2001;135:149-164.
6. Astiz ME, Rackow EC. Crystalloid-colloid controversy revisited. Crit Care Med 1999;27:34-35.
7. Cook DJ, Choi PTL. Albumin does not reduce death in critically ill patients with hypovolemia, burns or hypoalbuminemia. ACP J Club 1999;130:6.
8. Ferguson ND, Stewart TE, Etchells EE. Review of Cochrane injuries group albumin reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Intensive Care Med 1999;25:323-325.
9. Skillman JJ. Albumin: does the bell toll for thee? Transfusion 1999;39:120-122.
10. Starling EH. On the absorption of fluid from connective tissue spaces. J Physiol (Lond) 1896;19:312-326.
11. Herwaldt LA, Swartzendruber SK, Edmond MB, Embrey RP, Wilkerson KR, Wenzel RP, Perl TM. The epidemiology of hemorrhage related to cardiothoracic operations. Infect Control Hosp Epidemiol 1998;19:9-16.
12. Kannan S, Milligan KR. Moderately severe anaphylactoid reaction to pentastarch (200/0.5) in a patient with acute severe asthma. Intensive Care Med 1999;25:220-222.
13. Cittanova ML, Leblanc I, Legendre CH, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348:1620-1622.
14. von Hoegen I, Waller C. Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med 2001;29:994-996.
15. McCluskey A, Thomas AN, Bowles BJ, Kishen R. The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 1996;51:724-727.
16. Gales BJ, Erstad BL. Albumin audit results and guidelines for use. J Pharm Technol 1992;8:125-129.
17. Kapila A, Waldmann CS, Uncles DR, Addy EV. Survey of colloid usage in British intensive care units [abstract]. Clin Intensive Care 1995;6:A201.
18. Boldt J, Lenz M, Kumle B, Papsdorf M. Volume replacement strategies on intensive care units: results from a postal survey. Intensive Care Med 1998;24:147-151.
19. Miletin MS, Stewart TE, Norton PG. Influences on physicians' choices of intravenous colloids. Intensive Care Med 2002;28:917-924.
20. U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force, 2nd ed. Baltimore, MD: Williams & Wilkins; 1996.
21. Parving HP, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973;32:643-651.
22. Ramirez-Vick J, Vargas FF. Albumin modulation of paracellular permeability of pig vena caval endothelium shows specificity for pig albumin. Am J Physiol 1993;264:H1382-H1387.
23. Qiao R, Siflinger-Birnboim A, Lum H, Tiruppathi C, Malik AB. Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix. Am J Physiol 1993;265:C439-C446.
24. Michel CC, Phillips ME, Turner MR. The effects of native and modified bovine serum albumin on the permeability of frog mesenteric capillaries. J Physiol 1985;360:333-346.
25. Beck R, Bertolino S, Abbot SE, Aaronson PI, Smirnov SV. Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circ Res 1998;83:923-931.
26. Halliwell B. Albumin: an important extra cellular antioxidant. Biochem Pharmacol 1988;37:569-571.
27. Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Williams DM, Webb AR. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation: an in vitro study. Intensive Care Med 1994;20:37-41.
28. de Carvalho H, Matos JA, Bouskela E, Svensjo E. Vascular permeability increase and plasma volume loss induced by endotoxin was attenuated by hypertonic saline with or without dextran. Shock 1999;12:75-80.
29. Nielsen VG, Tan S, Brix AE, Baird MS, Parks DA. Hextend (hetastarch solution) decreases multiple organ injury and xanthine oxidase release after hepatoenteric ischemia-reperfusion in rabbits. Crit Care Med 1997;25:1565-1574.
30. Schnitzer JE, Carley WW, Palade GE. Specific albumin binding to microvascular endothelium in culture. Am J Physiol 1988;254:H425-H437.
31. Hancock BJ, Hoppensack M, Oppenheimer L. Do transvascular forces in isolated lobe preparations equilibrate? J Appl Physiol 1989;67:628-635.
32. Clifford CB, Wessels DA, Smith CD. Morphologic effects of hypervolemic administration of DBBF hemoglobin in the rat. Biomater Artif Cells Artif Organs 1990;18:321-328.
33. Qiao RL, Ying X, Bhattacharya J. Effects of hyperoncotic albumin on endothelial barrier properties of rat lung. Am J Physiol 1993;265:H198-H204.
34. McCandless BK, Powers MR, Cooper JA, Malik AB. Effect of albumin on hydraulic conductivity of pulmonary artery endothelial monolayers. Am J Physiol 1991;260:L571-L576.
35. Haraldsson B, Rippe B. Serum factors other than albumin are needed for the maintenance of normal capillary permselectivity in rat hindlimb muscle. Acta Physiol Scand 1985;123:427-436.
36. Anning PB, Finney SJ, Winlove CP, Evans TW. Effects of fluid resuscitation on LPS induced changes in vascular permeability and neutrophil function in vivo [abstract]. Am J Respir Crit Care Med 2001;161:A555.
37. Vollmar B, Lang G, Menger MD, Messmer K. Hypertonic hydroxyethyl starch restores hepatic microvascular perfusion in hemorrhagic shock. Am J Physiol 1994;266:H1927-H1934.
38. Bauer M, Marzi I, Ziegenfuss T, Seeck G, Buhren V, Larsen R. Comparative effects of crystalloid and small volume hypertonic hyperoncotic fluid resuscitation on hepatic microcirculation after hemorrhagic shock. Circ Shock 1993;40:187-193.
39. Horstick G, Lauterbach M, Kempf T, Bhakdi S, Heimann A, Horstick M, Meyer J, Kempski O. Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med 2002;30:851-855.
40. Nathan C, Xie QW, Halbwachs-Mecarelli L, Jin WW. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin). J Cell Biol 1993;122:243-256.
41. Rhee P, Wang D, Ruff P, Austin B, DeBraux S, Wolcott K, Burris D, Ling G, Sun L. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000;28:74-78.
42. Engel JM, Welters I, Rupp M, Langefeld T, Ruwoldt R, Menges T, Hempelmann G. Influence of colloid fluids on polymorphonuclear granulocyte function in vivo. Acta Anaesthesiol Scand 2001;45:385-389.
43. King TP. On the sulfhydryl group of human plasma albumin. J Biol Chem 1961;236:PC5.
44. Moran LK, Gutteridge JM, Quinlan GJ. Thiols in cellular redox signalling and control. Curr Med Chem 2001;8:763-772.
45. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 1999;11:1-14.
46. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JMC. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci 1998;95:459-465.
47. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JMC, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004;32:755-759.
48. Cantin AM, Paquette B, Richter M, Larivee P. Albumin mediated regulation of cellular glutathione and nuclear κB activation. Am J Respir Crit Care Med 2000;162:1539-1546.
49. Deb S, Sun L, Martin B, Talens E, Burris D, Kaufmann C, Rich N, Rhee P. Lactated Ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the Bax protein. J Trauma 2000; 49:47-53.
50. Simon DI, Stamler JS, Jaraki O, Keaney JF, Osborne JA, Francis SA, Singel DJ, Loscalzo J. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb 1993;13:791-799.
51. Martin G, Bennett-Guerrero E, Wakeling H, Mythen MG, el Moalem H, Robertson K, Kucmeroski D, Gan TJ. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth 2002;16:441-446.
52. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999;25:258-268.
53. Petroianu GA, Liu J, Maleck WH, Mattinger C, Bergler WF. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph. Anesth Analg 2000;90:795-800.
54. Bouchut JC, Lepape A, Carry PY. Effects of hydroxyethylstarch infusion on drug protein binding in critically ill patients. Eur J Anaesthesiol 2001;18:558-559.
55. Rasmussen I, Arvidsson D, Zak A, Haglund U. Splanchnic and total body oxygen consumption in experimental fecal peritonitis in pigs: effects of dextran and iloprost. Circ Shock 1992;36:299-306.
56. Pascual JL, Ferri LE, Chaudhury P, Seely AJ, Campisi G, Giannias B, Evans DC, Christou NV. Hemorrhagic shock resuscitation with a low molecular weight starch reduces neutrophil-endothelial interactions and vessel leakage in vivo. Surg Infect (Larchmt) 2001;2:275-287.
57. Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med 2002;30:300-305.
58. Friedman Z, Berkenstadt H, Preisman S, Perel A. A comparison of lactated Ringer's solution to hydroxyethyl starch 6% in a model of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg 2003;96:39-45.
59. Boura C, Caron A, Longrois D, Mertes PM, Labrude P, Menu P. Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects in skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance. Shock 2003;19:176-182.
60. Schertel ER, Allen DA, Muir WW, Hansen BD. Evaluation of a hypertonic sodium chloride/dextran solution for treatment of traumatic shock in dogs. J Am Vet Med Assoc 1996;208:366-370.
61. Marx G, Cobas MM, Schuerholz T, Vangerow B, Gratz KF, Hecker H, Sumpelmann R, Rueckoldt H, Leuwer M. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med 2002;28:629-635.
62. Zhang H, Voglis S, Kim CH, Slutsky AS. Effects of albumin and Ringer's lactate on production of lung cytokines and hydrogen peroxide after resuscitated hemorrhage and endotoxemia in rats. Crit Care Med 2003;31:1515-1522.
63. Morisaki H, Bloos F, Keys J, Martin C, Neal A, Sibbald WJ. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 1994;77:1507-1518.
64. Sun LL, Ruff P, Austin B, Deb S, Martin B, Burris D, Rhee P. Early up-regulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in rats with hemorrhagic shock and resuscitation. Shock 1999;11:416-422.
65. Deb S, Martin B, Sun L, Ruff P, Burris D, Rich N, DeBreux S, Austin B, Rhee P. Resuscitation with lactated Ringer's solution in rats with hemorrhagic shock induces immediate apoptosis. J Trauma 1999;46:582-588.
66. Kaneki T, Koizumi T, Yamamoto H, Fujimoto K, Kubo K, Shibamoto T. Effects of resuscitation with hydroxyethyl starch (HES) on pulmonary hemodynamics and lung lymph balance in hemorrhagic sheep: comparative study of low and high molecular HES. Resuscitation 2002; 52:101-108.
67. Lum H, Siflinger-Birnboim A, Blumenstock F, Malik AB. Serum albumin decreases transendothelial permeability to macromolecules. Microvasc Res 1991;42:91-102.
68. Haraldsson B, Rippe B. Serum factors other than albumin are needed for the maintenance of normal capillary permselectivity in rat hindlimb muscle. Acta Physiol Scand 1985;123:427-436.
69. Powers KA, Kapus A, Khadaroo RG, He R, Marshall JC, Lindsay TF, Rotstein OD. Twenty-five percent albumin prevents lung injury following shock/resuscitation. Crit Care Med 2003;31:2355-2363.
70. Zarins CK, Rice CL, Smith DE, John DA, Cammack BF, Peters RM, Virgilio RW. Role of lymphatics in preventing hypooncotic pulmonary edema. Surg Forum 1976;27:257-259.
71. Brigham KL, Woolverton WC, Blake LH, Staub NC. Increased sheep lung vascular permeability caused by Pseudomonas bacteremia. J Clin Invest 1974;54:792-804.
72. Kramer GC, Harms BA, Gunther RA, Renkin EM, Demling RH. The effects of hypoproteinemia on blood-to-lymph fluid transport in sheep lung. Circ Res 1981;49:1173-1180.
73. Guyton AC, Lindsey AW. Effect of elevated left atrial presure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959;7:649-657.
74. Rackow EC, Weil MH, Macneil AR, Makabali CG, Michaels S. Effects of crystalloid and colloid fluids on extravascular lung water in hypoproteinemic dogs. J Appl Physiol 1987;62:2421-2425.
75. Zarins CK, Rice CL, Peters RM, Virgilio RW. Lymph and pulmonary response to isobaric reduction in plasma oncotic pressure in baboons. Circ Res 1978;43:925-930.
76. Layon J, Duncan D, Gallagher TJ, Banner MJ. Hypertonic saline as a resuscitation solution in hemorrhagic shock: effects on extravascular lung water and cardiopulmonary function. Anesth Analg 1987;66:154-158.
77. Drummond JC, Patel PM, Cole DJ, Kelly PJ. The effect of the reduction of colloid oncotic pressure, with and without reduction of osmolality, on post-traumatic cerebral edema. Anesthesiology 1998;88:993-1002.
78. Sutin KM, Ruskin KJ, Kaufman BS. Intravenous fluid therapy in neurologic injury. Crit Care Clin 1992;8:367-408.
79. Belayev L, Busto R, Zhao W, Clemens JA, Ginsberg MD. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. J Neurosurg 1997;87:595-601.
80. Liu Y, Belayev L, Zhao W, Busto R, Belayev A, Ginsberg MD. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies. Eur J Pharmacol 2001;428:193-201.
81. Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 2001; 32:553-560.
82. Belayev L, Pinard E, Nallet H, Seylaz J, Liu Y, Riyamongkol P, Zhao W, Busto R, Ginsberg MD. Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke 2002;33:1077-1084.
83. Huh PW, Belayev L, Zhao W, Busto R, Saul I, Ginsberg MD. The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. Brain Res 1998;804:105-113.
84. Rodriguez de Turco EB, Belayev L, Liu Y, Busto R, Parkins N, Bazan NG, Ginsberg MD. Systemic fatty acid responses to transient focal cerebral ischemia: influence of neuroprotectant therapy with human albumin. J Neurochem 2002;83:515-524.
85. Tu YK, Heros RC, Karacostas D, Liszczak T, Hyodo A, Candia G, Zervas NT, Lagree K. Isovolemic hemodilution in experimental focal cerebral ischemia. 2. Effects on regional cerebral blood flow and size of infarction. J Neurosurg 1988;69:82-91.
86. Chorny I, Bsorai R, Artru AA, Talmor D, Benkoviz V, Roytblat L, Shapira Y. Albumin or hetastarch improves neurological outcome and decreases volume of brain tissue necrosis but not brain edema following closed-head trauma in rats. J Neurosurg Anesthesiol 1999;11:273-281.
87. Belayev L, Alonso OF, Huh PW, Zhao W, Busto R, Ginsberg MD. Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats. J Neurotrauma 1999;16:445-453.
88. Ginsberg MD, Zhao W, Belayev L, Alonso OF, Liu Y, Loor JY, Busto R. Diminution of metabolism/blood flow uncoupling following traumatic brain injury in rats in response to high-dose human albumin treatment. J Neurosurg 2001;94:499-509.
89. Cox CS Jr, Brennan M, Allen SJ. Impact of hetastarch on the intestinal microvascular barrier during ECLS. J Appl Physiol 2000;88:1374-1380.
90. Gist RS, Lu PY, Raj HG, Campbell C, Elkins TE. Use of sodium hetastarch (Hespan) solution for reduction of postoperative adhesion formation in rabbits. J Invest Surg 1996;9:369-373.
91. van Rijen EA, Ward JJ, Little RA. Effects of colloidal resuscitation fluids on reticuloendothelial function and resistance to infection after hemorrhage. Clin Diagn Lab Immunol 1998;5:543-549.
92. Oelschlager BK, Caragnano C, Carpenter J, Baker CC. Effect of resuscitation with hydroxyethyl starch and lactated Ringers on macrophage activity with hemorrhagic shock and sepsis. Shock 1994;2:141-144.
93. Tiras S, Yilmaz R, Ersin S, Kara E, Ozbal O, Ozdedeli E, Kapkac M. Hydroxyethyl starch solution: is it a new alternative way of treatment in bacterial translocation? Int Surg 1998;83:250-252.
94. Parth E, Jurecka W, Szepfalusi Z, Schimetta W, Gebhart W, Scheiner O, Kraft D. Histological and immunohistochemical investigations of hydroxyethyl-starch deposits in rat tissues. Eur Surg Res 1992;24:13-21.
95. Neveux N, De Bandt JP, Charrueau C, Savier E, Chaumeil JC, Hannoun L, Giboudeau J, Cynober LA. Deletion of hydroxyethylstarch from University of Wisconsin solution induces cell shrinkage and proteolysis during and after cold storage of rat liver. Hepatology 1997;25:678-682.
96. Vlahos AL, Matthew H, Yu P, Lucas CE, Ledgerwood AM. Effects of physiologic albumin and hespan levels on hepatocytes in vitro. J Trauma 2000;48:1075-1080.
97. Nielsen VG, Baird MS, Brix AE, Matalon S. Extreme, progressive isovolemic hemodilution with 5% human albumin, PentaLyte, or Hextend does not cause hepatic ischemia or histologic injury in rabbits. Anesthesiology 1999;90:1428-1435.
98. Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 1987;32:198-203.
99. Lipfert B, Standl T, Dullmann J, Helmchen U, Schulte am Esch J, Lorke DE. Histology and ultrastructure of liver and kidney following blood exchange with ultrapurified, polymerised bovine hemoglobin in comparison with hydroxyethyl starch. Lab Invest 1999;79:573-582.
100. Awad SS, Rich PB, Kolla S, Younger JG, Reickert CA, Downing VP, Bartlett RH. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin. ASAIO J 1997; 43:M745-M749.
101. Foley EF, Borlase BC, Dzik WH, Bistrian BR, Benotti PN. Albumin supplementation in the critically ill: a prospective, randomized trial. Arch Surg 1990;125:739-742.
102. Golub R, Sorrento JJ Jr, Cantu R Jr, Nierman DM, Moideen A, Stein HD. Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized study. Crit Care Med 1994;22:613-619.
103. Rubin H, Carlson S, DeMeo M, Ganger D, Craig RM. Randomized, double-blind study of intravenous human albumin in hypoalbuminemic patients receiving total parenteral nutrition. Crit Care Med 1997; 25:249-252.
104. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-2256.
105. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-214.
106. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377.
107. Shoemaker WC, Schluchter M, Hopkins JA, Appel PL, Schwartz S, Chang PC. Comparison of the relative effectiveness of colloids and crystalloids in emergency resuscitation. Am J Surg 1981;142:73-84.
108. Haupt MT, Rackow EC. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med 1982; 10:159-162.
109. Rackow EC, Mecher C, Astiz ME, Griffel M, Falk JL, Weil MH. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med 1989;17:394-398.
110. Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999;27:46-50.
111. London MJ, Franks M, Verrier ED, Merrick SH, Levin J, Mangano DT. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. J Thorac Cardiovasc Surg 1992;104:284-296.
112. Tigchelaar I, Gallandat Huet RC, Boonstra PW, van Oeveren W. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients. Perfusion 1998;13:297-303.
113. Tollofsrud S, Svennevig JL, Breivik H, Kongsgaard U, Ozer M, Hysing E, Mohr B, Seem E, Geiran O, Abdelnour M. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand 1995;39:671-677.
114. Wahba A, Sendtner E, Birnbaum DE. Fluid resuscitation with Haemaccel vs. human albumin following coronary artery bypass grafting. Thorac Cardiovasc Surg 1996;44:178-183.
115. Himpe D, Van Cauwelaert P, Neels H, Stinkens D, Van den Fonteyne F, Theunissen W, Muylaert P, Hermans C, Goossens G, Moeskops J. Priming solutions for cardiopulmonary bypass: comparison of three colloids. J Cardiothorac Vasc Anesth 1991;5:457-466.
116. Sade RM, Stroud MR, Crawford FA Jr, Kratz JM, Dearing JP, Bartles DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985;89:713-722.
117. Karanko MS. Effects of three colloid solutions on plasma volume and hemodynamics after coronary artery bypass surgery. Crit Care Med 2001;15:1015-1021.
118. Boldt J, Kling D, Herold C, Dapper F, Hempelmann G. Volume therapy with hypertonic saline hydroxyethyl starch solution in cardiac surgery. Anaesthesia 1990;45:928-934.
119. Diehl JT, Lester JL, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 1982; 34:674-679.
120. Gallagher JD, Moore RA, Kerns D, Jose AB, Botros SB, Flicker S, Naidech H, Clark DL. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg 1985;64:753-758.
121. Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg 1984;37:40-47.
122. Ley SJ, Miller K, Skov P, Preisig P. Crystalloid versus colloid fluid therapy after cardiac surgery. Heart Lung 1990;19:31-40.
123. London MJ, Ho JS, Triedman JK, Verrier ED, Levin J, Merrick SH, Hanley FL, Browner WS, Mangano DT. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989;97:785-797.
124. Mastroianni L, Low HB, Rollman J, Wagle M, Bleske B, Chow MS. A comparison of 10% pentastarch and 5% albumin in patients undergoing open-heart surgery. J Clin Pharmacol 1994;34:34-40.
125. Moggio RA, Rha CC, Somberg ED, Praeger PI, Pooley RW, Reed GE. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Crit Care Med 1983;11:943-945.
126. Munsch CM, MacIntyre E, Machin SJ, Mackie IJ, Treasure T. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg 1988;75:675-678.
127. Gallagher JD, Moore RA, Kerns D, Jose AB, Botros SB, Flicker S, Naidech H, Clark DL. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg 1985;64:753-758.
128. Sedrakyan A, Gondek K, Paltiel D, Elefteriades JA. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 2003;123:1853-1857.
129. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, Mullany CJ. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000;90:801-807.
130. Gallandat Huet RC, Siemons AW, Baus D, Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000;47:1207-1215.
131. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001;72:527-533.
132. Bickell WH, Wall MJ, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating truncal injuries. N Engl J Med 1994;331:1105-1109.
133. Moss GS, Lowe RJ, Jilek J, Levine HD. Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery 1981;89:434-438.
134. Nagy KK., Davis J, Duda J, Fildes J, Roberts R, Barrett J. A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circ Shock 1993;40:289-294.
135. Younes RN, Yin KC, Amino CJ, Itinoshe M, Rocha e Silva M, Birolini D. Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World J Surg 1998;22:2-5.
136. Lowe RJ, Moss GS, Jilek J, Levine HD. Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery 1977;81:676-683.
137. Modig J. Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome: a randomized study in man after traumatic-haemorrhagic shock. Resuscitation 1983;10:219-226.
138. Lowe RJ, Moss GS, Jilek J, Levine HD. Crystalloid versus colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Crit Care Med 1979;7:107-112.
139. Shah DM, Browner BD, Dutton RE, Newell JC, Powers SR Jr. Cardiac output and pulmonary wedge pressure: use for evaluation of fluid replacement in trauma patients. Arch Surg 1977;112:1161-1168.
140. Lucas CE, Ledgerwood AM, Higgins R, Weaver DW. Impaired pulmonary function after albumin resuscitation from shock. J Trauma 1980; 20:446-451.
141. Halonen P, Linko K, Myllyla G. A study of haemostasis following the use of high doses of hydroxyethyl starch 120 and dextran in major laparotomies. Acta Anaesthesiol Scand 1987;31:320-324.
142. Hedstrand U, Hogman C, Zaren B, Lundkvist B. Postoperative complications after blood replacement with or without plasma: a trial in elective surgery. Acta Chir Scand 1987;153:501-505.
143. Pertilla J, Salo M, Peltola O. Effects of different plasma subsitutes on plasma fibronectin concentration in patients undergoing abdominal surgery. Acta Anaesthesiol Scand 1990;34:304-307.
144. Prien T, Backhaus N, Pelster F, Pircher W, Bunte H, Lawin P. Effects of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth 1990;2:317-323.
145. McFarlane C, Lee A. A comparison of plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anaesthesia 1994;49:779-781.
146. Bothner U, Georgieff M, Vogt NH. Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: a randomized, controlled epidemiology study. Anesth Analg 1998;86:850-856.
147. Boutros AR, Ruess R, Olson L, Hoyt JL, Baker WH. Comparison of hemodynamic, pulmonary, and renal effects of use of three types of fluids after major surgical procedures on the abdominal aorta. Crit Care Med 1979;7:9-13.
148. Dawidson IJ, Willms CD, Sandor ZF, Coorpender LL, Reisch JS, Fry WJ. Ringer's lactate with or without 3% dextran-60 as volume expanders during abdominal aortic surgery. Crit Care Med 1991;19:36-42.
149. Skillman JJ, Restall DS, Salzman EW. Randomized trial of albumin vs. electrolyte solutions during abdominal aortic operations. Surgery 1975;78:291-303.
150. Shires GT, Peitzman AB, Albert SA, Illner H, Silane MF, Perry MO, Shires GT. Response of extravascular lung water to intraoperative fluids. Ann Surg 1983;197:515-519.
151. Marik PE, Iglesias J, Maini B. Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 1987;12:51-55.
152. Gold MS, Russo J, Tissot M, Weinhouse G, Riles T. Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery: a prospective, randomized study. Ann Surg 1990;211:482-485.
153. von Sommoggy S, Fraunhofer J, Jelen-Esselborn S, Stemberger A. Coagulation changes during aortofemoral bifurcation bypass: is volume and plasma substitution possible with hydroxyethyl starch alone? Anaesthesist 1990;39:353-360.
154. Rosencher N, Vassilieff N, Guigonis V, Toulon P, Conseiller C. Comparison of effects of Elohes and albumin on hemostasis in orthopedic surgery. Ann Fr Anesth Reanim 1992;11:526-530.
155. Lisander B, Jacobsson SA, Ivarsson I, Vegfors M, Engdahl O. Giving both enoxaparin and dextran increases the need for transfusion in revision hip arthroplasty. Eur J Surg 1996;162:861-866.
156. Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996;83:262-268.
157. Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D. Use of modified gelatin and hydroxyethyl starch for volume replacement in major orthopaedic surgery. Br J Anaesth 1997; 78:44-50.
158. Hiippala S, Linko K, Myllyla G, Lalla M, Hekali R, Makelainen A. Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Acta Anaesthesiol Scand 1995;39:228-235.
159. Vogt N, Bothner U, Brinkmann A, de Petriconi R, Georgieff M. Perioperative tolerance to large-dose 6% HES 200/0.5 in major urological procedures compared with 5% human albumin. Anaesthesia 1999;54:121-127.
160. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824.
161. Mangialardi RJ, Martin GS, Bernard GR, Wheeler AP, Christman BW, Dupont WD, Higgins SB, Swindell BB. Ibuprofen in Sepsis Study Group. Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Crit Care Med 2000;28:3137-3145.
162. Luz dP, Shubin H, Weil MH, Jacobson E, Stein L. Pulmonary edema related to changes in colloid osmotic and pulmonary artery wedge pressure in patients after acute myocardial infarction. Circulation 1975;51:350-357.
163. Stein L, Beraud JJ, Morissette M, Luz PD, Weil MH, Shubin H. Pulmonary edema during volume infusion. Circulation 1975;52:483-489.
164. Rackow EC, Fein IA, Siegel J. The relationship of the colloid oncotic pressure: pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest 1982;82:433-437.
165. Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT, Kaufman BS, Putnam D. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983;11:839-850.
166. Sibbald WJ, Driedger AA, Wells GA, Myers ML, Lefcoe M. The short-term effects of increasing plasma colloid osmotic pressure in patients with noncardiac pulmonary edema. Surgery 1983;93:620-633.
167. Tullis JL. Albumin. 2. Guidelines for clinical use. JAMA 1977;237:460-463.
168. Subcommittee of the Victorian Drug Usage Advisory Committee. Human albumin solutions: consensus statements for use in selected clinical situations. Med J Aust 1992;157:340-343.
169. Hauser CJ, Shoemaker WC, Turpin I, Goldberg SJ. Oxygen transport responses to colloids and crystalloids in critically ill surgical patients. Surg Gynecol Obstet 1980;150:811-816.
170. Metildi LA, Shackford SR, Virgilio RW, Peters RM. Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet 1984;158:207-212.
171. Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002;30:2175-2182.
172. Mitchell JP, Schuller D, Calandrino FS, Schuster DP. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 1992;145:990-998.
173. Gilroy J, Barnhart MI, Meyer JS. Treatment of acute stroke with dextran 40. JAMA 1969;210:293-298.
174. Gottstein U, Held K, Seldmeyer I. Cerebral and peripheral blood flow as affected by induced hemodilution. In: Hemodilution: theoretical basis and practical application. Basel, Switzerland: S. Karger; 1972. pp. 247-263.
175. Heiss WD, Prosenz P, Tschabitscher H, Lasek C, Herles HJ. Effect of low molecular dextran on total cerebral blood flow and on regional flow within ischemic brain lesions. Eur Neurol 1972;8:129-133.
176. Spudis EV, de la Tore D, Pikula L. Management of completed stroke with dextran 40: a community hospital failure. Stroke 1973;4:895-897.
177. Matthews WB, Oxbury JM, Grainger KM, Greenhall RC. A blind controlled trial of dextran 40 in the treatment of ischemic stroke. Brain 1976;99:193-206.
178. Gottstein U. Normovolemic and hypervolemic hemodilution in cerebrovascular ischemia. Bibl Haematol 1981;47:127-138.
179. Wood JH, Fleischer AS. Observations during hypervolemic hemodilution of patients with acute focal cerebral ischemia. JAMA 1982;248: 2999-3004.
180. Strand T, Asplund K, Eriksson S, Hagg E, Lithner F, Wester PO. A randomized controlled trial of hemodilution therapy in acute stroke. Stroke 1984;15:980-989.
181. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke. I. Results in the total patient population. Stroke 1987; 18:691-699.
182. Italian Acute Stroke Study Group. Haemodilution in acute stroke: results of the Italian haemodilution trial. Lancet 1988;1:318-321.
183. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: results of subgroup analysis. Stroke 1988;19:464-471.
184. Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke: results of a randomized multicenter trial using pentastarch. Stroke 1989;20:317-323.
185. Krack P, Haass A. Results of a double-blind hydroxyethylstarch hemodilution stroke study [abstract]. Stroke 1989;20:137.
186. Koller M, Haenny P, Hess K, Weniger D, Zangger P. Adjusted hypervolemic hemodilution in acute ischemic stroke. Stroke 1990;21:1429-1434.
187. Aichner FT, Fazekas F, Brainin M, Polz W, Mamoli B, Zeiler K. Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke 1998;29:743-749.
188. Mast H, Marx P. Neurological deterioration under isovolemic hemodilution with hydroxyethyl starch in acute cerebral ischemia. Stroke 1991;22:680-683.
189. Goslinga H, Eijzenbach V, Heuvelmans JH, van der Laan de Vries E, Melis VM, Schmid-Schonbein H, Bezemer PD. Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke. Stroke 1992;23:181-188.
190. Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev 2002;4:CD000103.
191. Mayer SA, Solomon RA, Fink ME, Lennihan L, Stern L, Beckford A, Thomas CE, Klebanoff LM. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. Neurosurgery 1998;42:759-767.
192. Yamakami I, Isobe K, Yamaura A. Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms. Neurosurgery 1987;21:303-309.
193. Kosnik EJ, Hunt WE. Postoperative hypertension in the management of patients with iptracranial arterial aneurysms. J Neurosurg 1976;45: 148-154.
194. Pritz MB, Giannotta SL, Kindt GW, McGillicuddy JE, Prager RL. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 1978;3:364-368.
195. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337-343.
196. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987;18:365-372.
197. Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000;31:383-391.
198. Wilfred L. Biology of acute renal failure: therapeutic implications. Kidney Int 1997;52:1102-1115.
199. Pockaj BA, Yang JC, Lotze MT, Lange JR, Spencer WF, Steinberg SM, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy. J Immunother 1994;15:22-28.
200. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomized study. Lancet 2001; 357:911-916.
201. Samii K, Rapin M, Roger LG, Regnier B. Haemodynamic study of patients with severe sepsis during haemodialysis. Intensive Care Med 1978;4:127-131.
202. Jardin F, Prost JF, Ozier Y, Margairaz A. Hemodialysis in septic patients: improvements in tolerance of fluid removal with concentrated albumin as the priming fluid. Crit Care Med 1982;10:650-652.
203. Wong PY, Carroll RE, Lipinski TL, Capone RR. Studies on the reninangiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion. Gastroenterology 1979;77:1171-1176.
204. Moller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995;109:1917-1925.
205. Ifudu O, Care of patients undergoing hemodialysis. N Engl J Med 1998;339:1054-1062.
206. Maggiore Q, Dattalo P, Piacenti M, Morales MA, Pelosi G, Pizzarelli F, Cerrai T. A pathophysiological overview of dialysis hypotension. Contrib Nephrol 1996;119:182-188.
207. Forni LG, Hilton PJ. Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 1997;336:1303-1309.
208. Van der Sande FM, Kooman JP, Barendregt JN, Nieman FH, Leunissen KM. Effect of intravenous saline, albumin, or hydroxyethylstarch on blood volume during combined ultrafiltration and hemodialysis. J Am Soc Nephrol 1999;10:1303-1308.
209. Van der Sande FM, Luik AJ, Kooman JP, Verstappen V, Leunissen KM. Effect of intravenous fluids on blood pressure course during hemodialysis in hypotensive-prone patients. J Am Soc Nephrol 2000; 11:550-555.
210. Riddez L, Hahn RG, Brismar B, Strandberg A, Svensen C, Hedenstierna G. Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med 1997;25:635-640.
211. Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001;93:811-816.
212. 2 gradient or gastric intramucosal pH in patients who have sepsis syndrome. Crit Care Med 2000;28:2254-2258.
213. Asfar P, Kerkeni N, Labadie F, Gouello JP, Brenet O, Alquier P. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intensive Care Med 2000;26:1282-1287.
214. Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995;130:423-429.
215. Garcia-Compean D, Zacarias-Villarreal J, Bahena-Cuevas H, Garcia Cantu DA, Estrella M, Garza TE, Valadez CR, Barragan RF. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial. Liver 1993;13:233-238.
216. Ruiz-del-Arbol L, Monescillo A, Jimenez W, Garcia-Plaza A, Arroyo V, Rodes J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997;113:579-586.
217. Runyon BA. Albumin infusion for spontaneous bacterial peritonitis. Lancet 1999;354:1838-1839.
218. Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, Torres M, Humbert P, Rimola A, Llach J. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988;94:1493-1502.
219. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, Viladomiu L, Rimola A, Morillas R. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991;325:829-835.
220. Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998;27:264-272.
221. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258-266.
222. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998;27:669-674.
223. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassull MA, Arroyo V, Rodes J. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994;20:1495-1501.
224. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soríano G, Guevara M, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341:403-409.
225. Velanovich V. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 1989;105:65-71.
226. Bisonni RS, Holtgrave DR, Lawler F, Marley DS. Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials. J Fam Pract 1991;32:387-390.
227. Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery 1997;122:609-616.
228. Wade CE, Grady JJ, Kramer GC, Younes RN, Gehlsen K, Holcroft JW. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma 1997;42:S61-S65.
229. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001;72:527-533.
230. Alderson P, Schierhout G, Roberts I, Bunn F. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2000;2:CD000567.
231. Bunn F, Lefebvre C, Li Wan Po A, Li L, Roberts I, Schierhout G, Albumin Reviewers. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2000;2:CD001208.
232. Bunn F, Alderson P, Hawkins V. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2001;2:CD001319.
233. Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery 1997;122:609-616.
234. Ioannidis JP, Cappelleri JC, Lau J. Issues in comparisons between meta-analyses and large trials. JAMA 1998;279:1089-1093.
235. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-542.
236. Cappelleri JC, Ioannidis JP, Schmid CH, de Ferranti SD, Aubert M, Chalmers TC, Lau J. Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA 1996;276:1332-1338.
237. DerSimonian R, Levine RJ. Resolving discrepancies between a meta-analysis and a subsequent large controlled trial. JAMA 1999;282:664-670.